Inventor
MOINGEON PHILIPPE
FR17 patents
⚠️ This page may combine multiple inventors who share the name “MOINGEON PHILIPPE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
STALLERGENES
5 patentsUS11027010B2Jun 8, 2021
Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
STALLERGENES0 citations56
US11015221B2May 25, 2021
Markers of immune response
STALLERGENES0 citations45
US11028441B2Jun 8, 2021
IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy
STALLERGENES0 citations43
US10884002B2Jan 5, 2021
Sialylated fetuin-A as a marker of immunotherapy efficacy
STALLERGENES0 citations43
US10610586B2Apr 7, 2020
Compositions for antigen-specific induction of tolerance
STALLERGENES0 citations43
MOINGEON PHILIPPE
4 patentsUS8632993B2Jan 21, 2014
Method for grass species identification
MOINGEON PHILIPPE2 citations58
US9795644B2Oct 24, 2017
Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
MOINGEON PHILIPPE0 citations45
US9555102B2Jan 31, 2017
Compositions for antigen-specific induction of tolerance
MOINGEON PHILIPPE0 citations42
US10190166B2Jan 29, 2019
Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy
MOINGEON PHILIPPE0 citations34
SANOFI PASTEUR LTD
2 patentsSTALLERGENES SA
2 patentsUS9822185B2Nov 21, 2017
Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa
STALLERGENES SA0 citations46
US9480748B2Nov 1, 2016
Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
STALLERGENES SA1 citations41